Patent US4871838A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4871838A Expired / Lapsed US ⏱️ 0.0 years remaining

Probes and methods for detecting activated ras oncogenes

Assignee: BOARD OF RIJKS UNIVERSITTEIT LEIDEN WASSENAARSEWEG 72 2333 AL LEIDEN NETHERLANDS A PUBLIC BODY OF NETHERLANDS
•
Filing: 1985-07-23
•
Granted: 1989-10-03
•
Expires: 2005-07-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Molecules complementary to nucleotide sequences encoding mutant ras protiens which contain a single-base mutation in the codon encoding amino acids at position 13, 12 or 61 have been produced. These molecules are useful in methods of detecting specific single-base mutations in altered ras genes and the specific cancers associated with such mutations.

Inventors

  • 👤 Johannes L. Bos
  • 👤 Alex J. Van der Eb

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 07:00
CPC Classifications
C; C07; C07H; C07H21/00; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6876; C12Q1/6883; C12Q1/6886; C12Q2600/00; C12Q2600/156; Y; Y10; Y10S; Y10S435/00; Y10S435/803; Y10S436/00; Y10S436/811; Y10S436/813

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 217 words
A molecule useful as a probe for detecting in a gene from a human subject which encodes a mutated N-ras protein, a single base mutation in the codon at position 13 of the N-ras gene, which mutation results in an amino acid being translated and incorporated into the mutated protein which is different from the amino acid translated and incorporated into a nonmutated ras protein comprising a nucleic acid of at least 12 but not more than 43 nucleotides having the formula:, 5'.sup.B-Q-D 3' wherein B represents from 0 to about 20 nucleotides having a sequence complementary to a sequence present in the gene which encodes the mutated N-ras protein, the gene sequence to which B is complementary encoding amino acids at the amino terminal side of the amino acid encoded at position 13 of the N-ras gene; wherein D represents from 0 to about 20 nucleotides having a sequence complementary to a sequence present in the gene which encodes the mutated N ras protein, the gene sequence to which D is complementary encoding amino acids at the carboxyl terminal side of the amino acid at position 13 of the N-ras gene; and wherein Q represents 3 nucleotides having a sequence complementary to the gene sequence which encodes an amino acid at position 13 other than glycine.
Claim 2
Dependent Claim 217 words
A molecule useful as a probe for detecting in a gene from a human subject which encodes a mutated N-ras protein, a single base mutation in the codon at position 13 of the N-ras gene, which mutation results in an amino acid being translated and incorporated into the mutated protein which is different from the amino acid translated and incorporated into a nonmutated ras protein comprising a nucleic acid of at least 12 but not more than 43 nucleotides having the formula:, 5'.sup.B-Q-D 3' wherein B represents from 0 to about 20 nucleotides having a sequence complementary to a sequence present in the gene which encodes the mutated N-ras protein, the gene sequence to which B is complementary encoding amino acids at the amino terminal side of the amino acid encoded at position 13 of the N-ras gene; wherein D represents from 0 to about 20 nucleotides having a sequence complementary to a sequence present in the gene which encodes the mutated N ras protein, the gene sequence to which D is complementary encoding amino acids at the carboxyl terminal side of the amino acid at position 13 of the N-ras gene; and wherein Q represents 3 nucleotides having a sequence complementary to the gene sequence which encodes an amino acid at position 13 other than glycine.
Claim 3
Dependent Claim 13 words
A nucleic acid molecule which is complementary to the molecule of claim 1.
Claim 4
Dependent Claim 15 words
A molecule of claim 1 wherein the codon Q is ACG, ACA, ACT,AGC,AAC or ATC.
Claim 5
Dependent Claim 20 words
A molecule of claim 1 wherein the nucleotide sequence of the molecule is TTCCCAACACGACCTGCTCC, TTCCCAACACAACCTGCTCC, TTCCCAACACTACCTGCTCC, TTCCCAACAGCACCTGCTCC, TTCCCAACAACACCTGCTCC, or TTCCCAACATCACCTGCTCC.
Claim 6
Dependent Claim 10 words
A molecule of claim I, labeled with a detachable moiety.
Claim 7
Dependent Claim 10 words
A molecule of claim 3, labeled with a detachable moiety.
Claim 8
Dependent Claim 10 words
A molecule of claim 4, labeled with a detachable moiety.

References Cited (Backward Citations)

US4535058A Cited
US4725550A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-10-02 1993-04-03 1993-10-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-10-02 1997-04-03 1997-10-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-10-02 2001-04-03 2001-10-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag